Skip to main content
. Author manuscript; available in PMC: 2015 May 21.
Published in final edited form as: Circulation. 2010 Feb 22;121(9):1069–1077. doi: 10.1161/CIRCULATIONAHA.109.906479

Figure 1.

Figure 1

Figure 1

Effects of rosuvastatin on the primary composite endpoint according to baseline characteristics. The dashed overall line indicates the overall hazard ratio for the entire cohort (men and women combined).